Shenzhen Sangel Venture Capital Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 3

Professionals

  • Investments
  • 71

  • Portfolio
  • 45

  • Exits
  • 10

Exits

Shenzhen Sangel Venture Capital General Information

Company Description

Founded in 2009, Shenzhen Sangel Venture Capital is a venture capital firm headquartered in Shenzhen, China. The firm seeks to invest in biomedical companies with a focus on life science, biotech, biopharma, medical devices, and digital health sectors.

Business Details

Year Founded
2009
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Accelerator/Incubator
Corporate Office
  • 2401/2402, Shenzhen Bay Venture Capital Building
  • Nanshan District
  • Shenzhen
  • China
+86 0755 0000 0000

Shenzhen Sangel Venture Capital Investments (71)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Proviva Therapeutics 22-Mar-2023 Early Stage VC 0000 Discovery Tools (Healthcare) Clinical Trials - Phase 1
BioTroy Therapeutics 07-Mar-2023 00000 00000 000.00 Biotechnology Pre-Clinical Trials
Ascentawits Pharmaceutical 16-Nov-2022 00000 00000 00.000 Pharmaceuticals Clinical Trials - Phase 2
Magpie Pharmaceuticals 15-Aug-2022 00000 00000 00000 Drug Discovery Clinical Trials - General
Gigaceuticals 15-Mar-2022 00000 00000 00.000 Drug Discovery Generating Revenue
Tyercan 24-Jan-2022 00000 00000 Drug Discovery Startup
Sparx (Drug Discovery) 31-Dec-2021 00000 00000 0000 Drug Discovery Clinical Trials - Phase 1
Shenzhen GSH Bio-Tech 01-Dec-2021 00000 00000 Biotechnology Generating Revenue
China Immunotech 10-Oct-2021 Early Stage VC 0000 Biotechnology Pre-Clinical Trials
Forward Pharmaceuticals(China) 08-Aug-2021 Later Stage VC 000.00 Drug Discovery Clinical Trials - Phase 1
You’re viewing 10 of 71 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Shenzhen Sangel Venture Capital Exits (10)

Company Name Exit Date Exit Type Exit Size
Refuge Biotech 03-Aug-2023 Out of Business
InnerMedical 31-Dec-2022 000000000 00000000 00000
3D Medicines 15-Dec-2022 000 00000
Bontac Bio-Engineering 25-Jun-2022 000000000 00000000
Predicine 01-Apr-2022 000000000 00000000
Sirnaomics 29-Dec-2021 000 000.00
Huaheng Biotech 12-Apr-2021 000 00000
VersaPeutics 01-Jul-2020 000000000000000000
Vivolight Medical 01-Sep-2017 Secondary Transaction - Private 00.00
BeyondSpring 09-Mar-2017 IPO 00.000
To view Shenzhen Sangel Venture Capital’s complete exits history, request access »

Shenzhen Sangel Venture Capital Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore Shenzhen Sangel Venture Capital‘s full profile, request access.

Request a free trial

Shenzhen Sangel Venture Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Shenzhen Sangel Venture Capital Management, Team & Partners (3)

Name Title Deals Funds Boards Office
He Nanxing Managing Partner 0 0 Shenzhen, China
Yanzhan Liu Investor Relation Director Shenzhen, China
You’re viewing 2 of 3 team members. Get the full list »

Shenzhen Sangel Venture Capital Co-Investors (67)

Name With Exits Lead Partner Series Industry
Highlight Capital 3 0 Series chart Industry bar
China Resources Capital Management 0 0 0 Series chart Industry bar
Co-Win Ventures 0 0 Series chart Industry bar
Share Capital 0 Series chart Industry bar
Shenzhen Gaoxin Investment 0 Series chart Industry bar
You’re viewing 5 of 67 co-investors. Get the full list »

Shenzhen Sangel Venture Capital FAQs

  • What is Shenzhen Sangel Venture Capital?

    Founded in 2009, Shenzhen Sangel Venture Capital is a venture capital firm headquartered in Shenzhen, China.

  • When was Shenzhen Sangel Venture Capital founded?

    Shenzhen Sangel Venture Capital was founded in 2009.

  • Where is Shenzhen Sangel Venture Capital headquartered?

    Shenzhen Sangel Venture Capital is headquartered in Shenzhen, China.

  • What is Shenzhen Sangel Venture Capital's total asset value?

    Shenzhen Sangel Venture Capital has around 00000 in total assets under management.

  • How many investments has Shenzhen Sangel Venture Capital made?

    Shenzhen Sangel Venture Capital has made 71 investments.

  • What has Shenzhen Sangel Venture Capital invested in?

    Shenzhen Sangel Venture Capital has made numerous investments in companies like Proviva Therapeutics, BioTroy Therapeutics, and Ascentawits Pharmaceutical within the Discovery Tools (Healthcare), Biotechnology, and Pharmaceuticals industries.

  • What has Shenzhen Sangel Venture Capital invested in recently?

    Shenzhen Sangel Venture Capital's latest investment was on 22-Mar-2023 in Proviva Therapeutics, a company within the Discovery Tools (Healthcare) industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »